Wow Shenzi you can actually type more than one sentence. I'm impressed with your hidden skills. Somebody must be getting worried about the on goings with the VVUS board.
Shenzi I'm still waiting for the dust. If VVUS had 600 reps we would be selling 40,000 Qsymia scripts per week.
I do believe there is more than one interested party in either a buyout or partnership. And I also suspect the problem in closing a deal is the current management and Sam Colins which would only be a concern to a partner not a buyout. Something is now up with Sam Colins quick resignation or he has been told he only has 1 week live.
They could be in deep talks with a BP who wants certain conditions met.
Makes sense the recent activity with both NT and Blackrock has something to do with Sam Colins departure. Things are happening behind closed doors.
Maybe Sam Collins is not liked by other institutions and that is why we have such a low share price. The very recent buying by NT and Blackrock has something to do with Sam Collins exit.
Yes they could. VVUS has the ability to do that because they have Stendra and Spedra launched now in over 40 countries and only need a few people to manage it.
I actually agree with you and have stated in the past PFE needs something new to offer their ED patients. Plus in the past PFE have stated they were considering the obesity market.
AUXL is currently in the process of creating a dedicated sales force for Stendra to capitalize on the new FDA label approval of 15 minute onset of action for Stendra. Since 60% of ED patients try a different ED drug every year it is important to get the Stendra name out there.
I'm still waiting for the dust in our faces from Belviq.
Remember the days when the shorts said nobody wants to partner with Spedra because of generic Viagra Europe? Remember when the shorts said nobody will partner with Stendra because the ED market in North America is crowded? We all started to believe it because it took a couple of years to happen. This could be the year 2015 for a Qsymia partnership.
I hope your right about Qsymia but right now I think Avanafil in 2015 is a better bet.